HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tine Van Bergen Selected Research

Macular Edema

12/2021Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 1. THR-149.
11/2021Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration.
10/2021Targeting Plasma Kallikrein With a Novel Bicyclic Peptide Inhibitor (THR-149) Reduces Retinal Thickening in a Diabetic Rat Model.
12/2018Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tine Van Bergen Research Topics

Disease

18Inflammation (Inflammations)
11/2021 - 11/2009
13Glaucoma
11/2021 - 11/2009
9Fibrosis (Cirrhosis)
11/2021 - 11/2009
8Choroidal Neovascularization
01/2021 - 01/2015
7Diabetic Retinopathy (Retinopathy, Diabetic)
11/2021 - 12/2017
7Cicatrix (Scar)
01/2019 - 11/2009
7Blister (Bulla)
11/2016 - 11/2009
4Macular Edema
12/2021 - 12/2018
4Macular Degeneration (Age-Related Maculopathy)
11/2021 - 01/2019
4Gliosis
10/2021 - 01/2019
4Pathologic Neovascularization
01/2020 - 11/2011
3Neoplasms (Cancer)
01/2020 - 04/2010
2Pathologic Processes
11/2021 - 01/2019
2Pain (Aches)
01/2021 - 12/2018
1Hyperglycemia
01/2022
1Insulin Resistance
01/2022
1Dry Eye Syndromes (Dry Eye Syndrome)
11/2021
1Blindness (Hysterical Blindness)
11/2021
1Retinal Vein Occlusion
11/2021
1Geographic Atrophy
01/2021
1Retinal Degeneration
01/2021
1Interstitial Cystitis (Interstitial Cystitis, Chronic)
01/2021
1Optic Nerve Injuries
12/2020
1Neuroinflammatory Diseases
12/2020
1Eye Diseases (Eye Disease)
01/2019
1Vascular Diseases (Vascular Disease)
01/2019
1Retinal Diseases
01/2019
1Ganglion Cysts (Ganglion)
01/2019
1Retinal Neovascularization
01/2019
1Carcinogenesis
01/2019
1Diabetes Mellitus
12/2018
1Edema (Dropsy)
12/2018
1Corneal Neovascularization
09/2015
1Corneal Injuries
09/2015
1Burns
09/2015
1Disease Progression
07/2015
1Hyperemia
02/2014
1Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2014

Drug/Important Bio-Agent (IBA)

9Retinaldehyde (Retinal)IBA
11/2021 - 12/2018
9CollagenIBA
12/2017 - 11/2009
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 11/2009
5Bevacizumab (Avastin)FDA Link
11/2015 - 11/2009
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 12/2013
4rho-Associated KinasesIBA
09/2015 - 02/2014
4AntibodiesIBA
08/2015 - 04/2010
3Plasma KallikreinIBA
12/2021 - 12/2018
3IntegrinsIBA
11/2021 - 11/2016
3CytokinesIBA
10/2021 - 08/2015
2RNA (Ribonucleic Acid)IBA
10/2020 - 01/2020
2afliberceptIBA
01/2019 - 12/2017
2Streptozocin (Streptozotocin)FDA Link
01/2019 - 12/2017
2Oxygen (Dioxygen)IBA
01/2019 - 05/2015
2Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
08/2015 - 08/2013
2fluorescein isothiocyanate dextranIBA
05/2015 - 01/2015
2Monoclonal AntibodiesIBA
08/2013 - 11/2009
1Advanced Glycation End ProductsIBA
01/2022
1arginyl-glycyl-aspartic acidIBA
11/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1sodium iodateIBA
01/2021
1Biological ProductsIBA
01/2021
1Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link
01/2021
1Interleukin-33IBA
01/2021
1heparanaseIBA
01/2021
1MetalsIBA
10/2020
1Pharmaceutical PreparationsIBA
01/2019
1Cholinergic Agents (Cholinergics)IBA
01/2019
1BradykininIBA
12/2018
1Peptides (Polypeptides)IBA
12/2018
1CLT-28643IBA
11/2016
1Ophthalmic Solutions (Eye Drops)IBA
11/2016
1Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
09/2015
1AlkaliesIBA
09/2015
1Protein Kinases (Protein Kinase)IBA
09/2015
1DC101 monoclonal antibodyIBA
01/2015
1Texas redIBA
01/2015
1Fluorescein-5-isothiocyanate (FITC)IBA
01/2015
1Dextrans (Dextran)FDA Link
01/2015
1LectinsIBA
01/2015
1Y-39983IBA
02/2014
1SolutionsIBA
01/2014
1SaltsIBA
01/2014
1simtuzumabIBA
08/2013
1pegaptanib (Macugen)FDA Link
11/2011
1Protein Isoforms (Isoforms)IBA
11/2011
1CarcinogensIBA
04/2010

Therapy/Procedure

10Filtering Surgery
11/2016 - 11/2009
7Lasers (Laser)
01/2021 - 01/2015
5Therapeutics
11/2021 - 04/2010
5Trabeculectomy (Trabeculoplasty)
01/2014 - 11/2009
3Injections
10/2021 - 11/2016
1Surgical Sponges (Surgical Sponge)
11/2015
1Plasmapheresis
07/2015
1Intravitreal Injections
01/2015
1Intracameral Injection
12/2013